LifeVantage Price Performance
Shares of LFVN opened at $4.09 on Tuesday. The stock has a market cap of $51.49 million, a PE ratio of 5.84 and a beta of 1.21. LifeVantage has a 12 month low of $3.80 and a 12 month high of $8.28. The stock’s 50-day moving average is $4.34 and its two-hundred day moving average is $4.74.
LifeVantage (NASDAQ:LFVN – Get Rating) last announced its quarterly earnings data on Tuesday, May 3rd. The company reported $0.12 earnings per share for the quarter. The company had revenue of $50.00 million during the quarter. LifeVantage had a net margin of 4.49% and a return on equity of 27.19%. During the same period in the prior year, the business earned $0.20 earnings per share. On average, research analysts anticipate that LifeVantage will post 0.54 earnings per share for the current year.
Institutional Inflows and Outflows
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.
- Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
- MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
- The Colgate-Palmolive Growth Outlook Brightens
- Deep Value High Yield Newell Brands Is Ready To Bottom
- These Stocks Outperformed Last Time There Was A Recession
- Does Rivian’s Stock Still Have A Future?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.